STACEY MEEK: Open Payments
NPI 1669108791 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 17 payments from 10 companies in 2025. Trend: 2023 $198 · 2024 $160 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $166 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Indivior Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: ABILIFY MAINTENA, COBENFY, CAPLYTA, SUBLOCADE, AUSTEDO XR, ABILIFY ASIMTUFII, Auvelity, AIRSUPRA.
Industry payments across DE — which companies pay providers there.
